127 related articles for article (PubMed ID: 11944612)
1. Ten years of colony-stimulating factors: what have we learned? Introduction.
Sylvester RK
Am J Health Syst Pharm; 2002 Apr; 59(7 Suppl 2):S3-5; quiz S28-9. PubMed ID: 11944612
[No Abstract] [Full Text] [Related]
2. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
Bhana N
Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
[TBL] [Abstract][Full Text] [Related]
3. Myeloid growth factors clinical practice guidelines in oncology.
Crawford J; Althaus B; Armitage J; Blayney DW; Cataland S; Dale DC; Demetri GD; Foran J; Heaney ML; Htoy S; Kloth DD; Lyman GH; Michaud L; Motl S; Vadhan-Raj S; Wong MK;
J Natl Compr Canc Netw; 2005 Jul; 3(4):540-55. PubMed ID: 16038645
[No Abstract] [Full Text] [Related]
4. [The use of a colony-stimulating factor (G-CSF) in iatrogenic neutropenias].
Martínez Ruiz M; Llobell Segui G; Peralba Vaño JI; Toral Revuelta JR; Mellado del Rey F; González de Aledo GB
An Med Interna; 1992 Dec; 9(12):624. PubMed ID: 1283082
[No Abstract] [Full Text] [Related]
5. Drugs recently released in Belgium. Filgrastim--terbinafine.
Harvengt C
Acta Clin Belg; 1992; 47(3):217-22. PubMed ID: 1332353
[No Abstract] [Full Text] [Related]
6. New treatment options for managing chemotherapy-induced neutropenia.
Valley AW
Am J Health Syst Pharm; 2002 Aug; 59(15 Suppl 4):S11-7. PubMed ID: 12166032
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study.
Tan H; Tomic K; Hurley D; Daniel G; Barron R; Malin J
Curr Med Res Opin; 2011 Jan; 27(1):79-86. PubMed ID: 21091127
[TBL] [Abstract][Full Text] [Related]
8. Filgrastim for mesalazine-associated neutropenia.
Wyatt S; Joyner MV; Daneshmend TK
Lancet; 1993 Jun; 341(8858):1476. PubMed ID: 8099166
[No Abstract] [Full Text] [Related]
9. Cost considerations in therapy with myeloid growth factors.
Glaspy JA; Jakway J
Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S19-26. PubMed ID: 7689789
[TBL] [Abstract][Full Text] [Related]
10. Frequency of febrile neutropenia in breast cancer patients receiving epirubicin and docetaxel/paclitaxel with colony-stimulating growth factors: a comparison of filgrastim or lenograstim with pegfilgrastim.
Schippinger W; Holub R; Dandachi N; Bauernhofer T; Samonigg H
Oncology; 2006; 70(4):290-3. PubMed ID: 16899982
[TBL] [Abstract][Full Text] [Related]
11. Colony-stimulating factors for the management of neutropenia in cancer patients.
Dale DC
Drugs; 2002; 62 Suppl 1():1-15. PubMed ID: 12479591
[TBL] [Abstract][Full Text] [Related]
12. Advances in the use of colony-stimulating factors for chemotherapy-induced neutropenia.
Dale DC
J Support Oncol; 2005; 3(2 Suppl 1):39-41. PubMed ID: 15794500
[No Abstract] [Full Text] [Related]
13. Filgrastim for treatment of neutropenia in a neonate.
Berndt EM; Stavris MA; Hanna M; Allen P; Kulick J
Am J Health Syst Pharm; 1999 May; 56(10):995-7. PubMed ID: 10365725
[No Abstract] [Full Text] [Related]
14. Neutropenia related to valacyclovir and valganciclovir in 2 renal transplant patients and treatment with granulocyte colony stimulating factor: a case report.
Keles M; Yildirim R; Uyanik A; Turkmen M; Bilen Y; Aydinli B; Cetinkaya R; Polat KY
Exp Clin Transplant; 2010 Jun; 8(2):181-3. PubMed ID: 20565377
[TBL] [Abstract][Full Text] [Related]
15. Using filgrastim efficiently.
Dranitsaris G
Pharmacoeconomics; 1996 May; 9(5):466-8. PubMed ID: 10161379
[No Abstract] [Full Text] [Related]
16. Colony-stimulating factors: clinical status.
Gabrilove JL
Important Adv Oncol; 1991; ():215-37. PubMed ID: 1714420
[No Abstract] [Full Text] [Related]
17. Prophylactic granulocyte colony-stimulating factor treatment for acquired chronic severe neutropenia in pregnancy.
Sangalli MR; Peek M; McDonald A
Aust N Z J Obstet Gynaecol; 2001 Nov; 41(4):470-1. PubMed ID: 11787932
[No Abstract] [Full Text] [Related]
18. G-CSF: filgrastim, lenograstim and biosimilars.
Welte K
Expert Opin Biol Ther; 2014 Jul; 14(7):983-93. PubMed ID: 24707817
[TBL] [Abstract][Full Text] [Related]
19. Comparison of sargramostim and filgrastim in the treatment of chemotherapy-induced neutropenia.
Stull DM; Bilmes R; Kim H; Fichtl R
Am J Health Syst Pharm; 2005 Jan; 62(1):83-7. PubMed ID: 15658078
[No Abstract] [Full Text] [Related]
20. Clinical applications of colony-stimulating factors: a historical perspective.
Sylvester RK
Am J Health Syst Pharm; 2002 Apr; 59(7 Suppl 2):S6-12. PubMed ID: 11944613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
